Sino Biopharmaceutical's market cap is currently ―. The company's EPS TTM is $0.016; its P/E ratio is 21.12; and it has a dividend yield of 3.02%. Sino Biopharmaceutical is scheduled to report earnings on August 29, 2024, and the estimated EPS forecast is $0.01. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 22	Dec 21	Jun 21	Dec 20	Sep 20
Income Statement	-
Total Revenue	-	-	-	¥ 5.52B	¥ 5.48B
Gross Profit	-	-	-	¥ 4.41B	¥ 4.20B
EBIT	-	-	-	¥ 1.33B	¥ 1.22B
EBITDA	-	-	-	¥ 1.33B	¥ 1.22B
Net Income Common Stockholders	-	-	-	¥ 920.59M	¥ 609.88M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	¥ 15.67B	¥ 15.79B	¥ 10.44B	¥ 16.43B	¥ 18.53B
Total Assets	¥ 64.93B	¥ 60.54B	¥ 56.21B	¥ 47.21B	¥ 66.20B
Total Debt	¥ 12.02B	¥ 12.12B	¥ 13.65B	¥ 14.21B	¥ 14.28B
Net Debt	¥ -3.66B	¥ -3.68B	¥ 3.21B	¥ -2.22B	¥ -4.25B
Total Liabilities	-	¥ 22.81B	¥ 25.10B	¥ 24.79B	¥ 25.74B
Stockholders Equity	¥ 30.21B	¥ 30.29B	¥ 24.58B	¥ 16.75B	¥ 31.67B
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in CNY

Sino Biopharmaceutical Earnings and Revenue History

Income Statement >

Sino Biopharmaceutical Debt to Assets

Balance Sheet >

Sino Biopharmaceutical Cash Flow

Cash Flow >

Sino Biopharmaceutical Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing